Skip to main content

Military Health System

Clear Your Browser Cache

This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.

Army Announces FDA Clearance of Field Deployable TBI Blood Test

Image of Military personnel standing in the snow preparing to fire a missile . Soldiers from 1st/120th Field Artillery, Wisconsin National Guard, prepare to fire a M-777 Howitzer during Winter Strike 21 at Camp Grayling Maneuver Center, Michigan in Jan. 2021. Soon the Army should have a field-deployable means to detect and evaluate soldiers for TBI (Photo by: Air National Guard photo by Master Sgt. Dan Heaton).

The U.S. Army Medical Materiel Development Activity, in partnership with Abbott, announced the U.S. Food and Drug Administration approval of the Abbott i-STAT™ Alinity™ Traumatic Brain Injury plasma assay, a rapid blood test for TBI in January.

Between 2000 and 2019, more than 400,000 service members experienced a TBI as a result of combat injuries and training accidents, as well as everyday activities such as sporting events.

Developing a field-deployable solution for the detection and evaluation of TBI among our wounded service members serving at home and deployed overseas has been a top priority for the Department of Defense for more than a decade.

"A rapid test for TBI is a critical addition to our downrange capability to care for the brain health of our most important weapon system, the Warfighter, and help maintain a high state of readiness across the Force," said Army Brig. Gen. Michael Talley, commanding general for the U.S. Army Medical Research and Development Command and Fort Detrick, Maryland.

The i-STAT Alinity TBI plasma assay can identify two brain-specific protein markers that rapidly appear in the blood following a TBI. This blood test will provide medical professionals with objective markers that indicate injury to the brain, as opposed to relying on subjective descriptions of the injury-causing incident, reduce the need for head Computed Tomography scans.

"A blood-based biomarker laboratory assay (blood test) for TBI will greatly enhance the ability of DOD medical personnel to objectively assess Service Members who have suffered a suspected TBI. The ability to avoid unnecessary evacuations for head CT scans could really impact the efficiency of TBI management,” said Dr. Krista Caudle, product manager for USAMMDA's Warfighter Brain Health Project Management Office.

The goal for initial implementation of the laboratory assay is to assist with the management of patients with a suspected TBI, particularly focusing on the areas where Service Members would be required to be evacuated from the operational setting to obtain a CT scan of the head. The overall objective is to have a logistically suitable, whole-blood, point-of-care TBI biomarker test with rapid turnaround time.

"The laboratory assay for TBI product development program is an example of how USAMRDC and private industry can share a common vision and achieve a common goal. Over the years, the program progressed through basic science studies at Walter Reed Army Institute of Research and USAMRDC's Combat Casualty Care Research Program, then into product development and clinical trials in USAMMDA, and ultimately U.S. FDA clearance," said Caudle.

The FDA-approved Banyan Biomarkers, Inc., Brain Trauma Indicator™, also funded by USAMMDA, laid the groundwork and served as a foundation for the i-STAT Alinity TBI plasma assay. The DOD partnered with Abbott to develop the TBI biomarkers into a field-deployable laboratory platform, which is an easy-to-use TBI cartridge utilized in the i-STAT Alinity device, the new version of the i-STAT 1 that is currently fielded by the U.S. Army. Recent user assessments have established preliminary suitability of the assay and device in operational laboratory settings for the Army. Future testing will confirm system suitability and enable fielding of this capability.

The laboratory assay for TBI point-of-care biomarker effort has been funded by the U.S. Army and is managed by USAMMDA's Warfighter Brain Health Project Management Office.

You also may be interested in...

Infographic
Feb 7, 2023

Brain Injury Awareness Month: Hearing and Vision 1

Brain Injury Awareness: Our hearing and vision providers have unique capabilities to support vision and hearing dysfunction related to TBI.

Our providers are prepared and ready to treat vision and hearing dysfunctions associated with TBI. Learn more: https://vce.health.mil/Clinicians-and-Researchers/Clinical-Practice-Recommendations, and https://hearing.health.mil/For-Providers. #BIAMonth

Infographic
Feb 7, 2023

Brain Injury Awareness Month: Fact 1

Brain Injury Awareness Month Facts: More than 460k TBIs reported since 2000 by members of the U.S. Armed Forces

Do you or a loved one have a #TBI? You aren’t alone. Service members have reported more than 460,000 TBIs since 2000. Find tools to protect yourself from further injury, talk to your provider about your treatment, and optimize your recovery. Learn more: https://health.mil/BIAMonth. #BIAMonth #ProtectTreatOptimize #BeABrainWarrior

Infographic
Feb 7, 2023

Brain Injury Awareness Month: Infographic

Brian Injury Awareness month infographic

Even a mild traumatic brain injury can impact mission readiness and the ability to deploy. #BeABrainWarrior by understanding the signs and symptoms of TBI and knowing when to seek care. TBI is treatable & recovery is possible. https://health.mil/BIAMonth #BIAMonth

Infographic
Feb 7, 2023

Brain Injury Awareness Month: Fact 2

Brain Injury Awareness Month Facts: 82.3% Categorized as Mild TBI, also known as concussion

#DYK? Most #TBI happen in garrison, not on the battlefield. Find fact sheets to help you becomes a #BeABrainWarrior and protect your head anytime, anywhere. https://health.mil/BIAMonth. #BIAMonth #ProtectTreatOptimize

Infographic
Feb 7, 2023

Brain Injury Awareness Month: Hearing and Vision 2

Brain Injury Awareness: Heads Up

Head injuries, especially from a blast, are one of the most common combat-related injuries among deployed service members. Typical symptoms after a head injury are trouble hearing speech in noisy settings, ringing or other sounds in your ears or head, or dizziness when you move your head while walking or bending down. Talk to your provider if you have ...

Publication
Jan 23, 2023

Progressive Return to Activity: Primary Care for Acute Concussion Management

.PDF | 471.02 KB

The Progressive Return to Activity (PRA): Primary Care for Acute Concussion Management clinical recommendation is an evidence-based return to activity protocol for primary care managers and concussion/traumatic brain injury (TBI) clinic providers. The PRA is a six-step approach that begins after the provider performs the Military Acute Concussion ...

Refine your search
Last Updated: July 11, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery